[1] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015.CA Cancer J Clin 2016,66:115-132.
[2] 中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版).中华肝脏病杂志,2020,28:112-128.
[3] Dubuisson J,Cosset FL.Virology and cell biology of the hepatitis C virus life cycle:an update.J Hepatol,2014;61:S3-13.
[4] Zuo C,Xia M,Wu Q,et al.Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).Oncol Lett,2015,9:527-534.
[5] Choo QL,Kuo G,Weiner AO,et al.Isolation of a cDNA clone derived from a blood-borne non-A,non-B viral hepatitis genome.Science,1989,244:359-362.
[6] Boltjes A,Movita D,Boonstra A,et al.The role of Kupffer cells in hepatitis B and hepatitis C virus infections.J Hepatol,2014,61:660-671.
[7] Waris G,Siddiqui A.Regulatory mechanisms of viral hepatitis B and C.J Biosci,2003,28:311-321.
[8] 杨宗燕,张洁利.HBV和HCV相关性肝细胞癌的临床特征分析.中华保健医学杂志,2018,20:426-428.
[9] 王月姣,宋海燕,邢练军,等.HBV/HCV感染诱导肝细胞癌的病理机制.临床肝胆病杂志,2017,33:1381-1386.
[10] Wu J,Meng Z,Jiang M,et al.Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.Immunology,2010,129:363-374.
[11] Huang XW,Yang J,Dragovic AF,et al.Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis.Clin Cancer Res,2006,12:2849-2855.
[12] Wu ZF,Zhou XH,Hu YW,et al.TLR4-dependant immune response,but not hepatitis B virus reactivation,is important in radiation-induced liver disease of liver cancer radiotherapy.Cancer Immunol Immunother,2014,63:235-245.
[13] Chou CH,Chen PJ,Lee PH,et al.Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells.Clin Cancer Res,2007,13:851-857.
[14] 陈凤娟.慢性HBV感染者PD-1表达与HBV DNA和HBeAg的相关性研究.中山大学;2009.
[15] Ramalho F.Hepatitis C virus infection and liver steatosis.Antiviral Res,2003,60:125-127.
[16] Angelidakis G,Krishnan S,Cabrera NL,et al..Virologic Impact of Radiotherapy in Hepatitis C Virus-Infected Patients With Hepatocellular Carcinoma.Hepatology,2020,72:775-777.
[17] Chou CH,Chen PJ,Lee PH,et al.Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells.Clin Cancer Res,2007,13:851-857.
[18] Wang CC,Kao JH.How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma? Expert Opin Pharmacother,2016,17:911-919.
[19] Zhang L.Autophagy in hepatitis B or C virus infection:An incubator and a potential therapeutic target.Life Sci,2020,242:117206.
[20] Gauthiez E,Habfast-Robertson I,Rueger S,et al..A systematic review and meta-analysis of HCV clearance.Liver Int,2017,37:1431-1445.
[21] 张建丽.在全球无干扰素的DAA治疗方案与HCV相关HCC患者生存率增加有关.临床肝胆病杂志,2020,36:56.
[22] 喻一奇,张文宏.HCV感染者接受直接抗病毒药物治疗期间发生肝细胞癌风险.肝脏,2017,22:1083-1084.
[23] Singal AG,Rich NE,Mehta N,et al..Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.Gastroenterology,2019,157:1253-1263. |
